Dataset For: CRISPRCas9 Genome Editing-Based Preclinical Theranostics, Biomarkers and Drug Delivery Systems for Cancer Applications
Abstract
The dataset present here emphasizes the transformative potential of CRISPR/Cas9-integrated theranostics, which combines targeted gene editing and advanced imaging for enhanced and effecient therapeutic monitoring for cancer treatment.
Fields of Study & Subjects
CRISPR and Genetic Engineering
Nanoplatforms for cancer theranostics
Cancer Research and Treatments
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 January 2026
- Language
- EN
- Document type
- Dataset